Determination of α1-adrenoceptor antagonists in plasma by radioreceptor assay

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 3, 1996, Pages 289-294

  Yamada, S ^a   Tanaka, C ^a   Suzuki, M ^a   Ohkura, T ^a   Kimura, R ^a   Kawabe, K ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Plasma; Radioreceptor assay; 3H Prazosin; 1 Adrenoceptor antagonists

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; PRAZOSIN; TAMSULOSIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BRAIN CORTEX; DOG; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG RECEPTOR BINDING; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; RAT;

EID: 0029991657     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(95)01596-5     Document Type: Article

References (32)

1. D.B. Barnett and S.R. Nahorski, Trends Pharmacol. Sci., 3 (1983) 407-409.
2. P. Crevat-Pisano, C. Hariton, P.H. Rolland and J.P. Cano, J. Pharm. Biomed. Anal., 4 (1986) 697-716.
3. K. Ensing, I.J. Bosman, A.C.G. Egberts, J.P. Franke and R.A. de Zeeuw, J. Pharm. Biomed. Anal., 12 (1994) 53-58.
4. J.W. Ferkany, Life Sci., 41 (1987) 881-884.
5. J. Smisterava, K. Ensing and R.A. de Zeeuw, J. Pharm. Biomed. Anal., 12 (1994) 723-745.
6. T. Kaila, J. Pharm. Sci., 80 (1991) 296-299.
7. S.R. Nahorski, M.I. Batta and D.B. Barnett, Eur. J. Pharmacol., 52 (1978) 393-396.
8. I.E. Creese and S.H. Snyder, Nature (London), 270 (1977) 180-182.
9. M.L. Rao, Psychopharmacology, 90 (1986) 548-553.
10. M.L. Rao, W.A. Brown and R. Wagner, Ther. Drug Monit., 10 (1988) 184-187.
11. P. Hunt, J.M. Husson and J.P. Raynaud, J. Pharm. Pharmacol., 31 (1979) 448-451.
12. R.G. Dorow, J. Seidler and H.H. Schneider, Br. J. Clin. Pharmacol., 13 (1982) 561-565.
13. E.L. Manchester, E. Giesbrecht and S. J. Soldin, Ther. Drug Monit., 9 (1987) 61-66.
14. G. Caselli, M.P. Ferrari, G. Tonon, G. Clavenna and M. Borsa, J. Pharm. Sci., 80 (1991) 173-177.
15. R.J. Goula, K.M.M. Murphy and S.H. Snyder, Life Sci., 33 (1983) 2665-2672.
16. R.A. Janis, G.J. Krol, A.J. Noe and M. Pan, J. Clin. Pharmacol., 23 (1983) 266-273.
17. S. Yamada, Y. Matsuoka, N. Suzuki, N. Sugimoto, Y. Kato and R. Kimura, Pharm. Res., 9 (1992) 1227-1230.
18. A.C. Lane, J.D. Nichols, N.D. Steel, K. Sugden and D.S. Walter, J. Pharm. Biomed. Anal., 6 (1988) 787-792.
19. R. Kelly, Diagn. Med., 7 (1984) 37-40.
20. L.T. Kucharski, P. Alexander, L. Tune and J. Coyle, Psychopharmacol. Berlin, 82 (1984) 194-198.
21. S.H. Snyder, Wellcome Trends Psychiatry (1985) 9-14.
22. H. Hedlund, K.-E. Andersson and A. Ek, J. Urol., 130 (1983) 275-278.
23. K. Kawabe, N. Moriyama, S. Yamada and N. Taniguchi, Int. J. Urol., 3 (1994) 203-211.
24. H. Lepor, S. Auerbach, A. Puras-Baez, P. Narayan, M. Soloway, F. Lowe, T. Moon, G. Leifer and P. Madsen, J. Urol., (1992) 1467-1474.
25. M.I. Wilde, A. Fitton and D. McTavish, Drugs, (1993) 410-429.
26. J. Dokladalova, S.J. Coco, P.R. Lemke, G.T. Quercia and J.J. Korst, J. Chromatogr., 224 (1981) 33-41.
27. Y. Soeishi, M. Kobori, S. Kobayashi and S. Higuchi, J. Chromatogr., 533 (1990) 291-296.
28. T.M. Twomey and D.C. Hobbs, J. Pharm. Sci., 67 (1978) 1468-1469.
29. Y.G. Yee, P.C. Rubin and P. Meffin, J. Chromatogr., 172 (1979) 313-318.
30. S. Yamada, Y. Kagawa, H. Ushijima, N. Takayanagi, T. Tomita and E. Hayashi, Brain Res., 410 (1987) 212-218.
31. S. Yamada, N. Ashizawa, H. Ushijima, K. Nakayama, E. Hayashi and K. Honda, J. Pharmacol. Exp. Ther., 242 (1987) 326-330.
32. K. Yamaoka, Y. Tanigawara, T. Nakagawa and T. Uno, J. Pharmacobio-Dyn., 4 (1981) 879-885.